Where Conditions Go Undetected.
Every care setting. Every transition point. Every moment a condition could be caught — and isn't.
Intake.
Catch conditions before they compound.
A patient arrives at intake. They're assessed for their presenting complaint. But what about the depression they haven't mentioned? The early cognitive decline they don't notice? The respiratory markers that won't show symptoms for another six months? Standard intake misses what isn't obvious. GIA® screens for 46 conditions during a single conversation — before the patient ever sees a clinician. Conditions caught at intake cost a fraction of what they cost when caught at discharge.
Cognitive.
Detect decline before it becomes crisis.
In post-acute and long-term care settings, cognitive decline develops gradually. Staff turnover means the person who noticed a change last month isn't there this month. Annual assessments miss what happens in between. GIA® screens every patient, every visit. Speech biomarkers detect early indicators of Alzheimer's, MCI, depression, anxiety, and PTSD — conditions that affect over 60% of post-acute care residents but are identified in fewer than 40% of cases. The difference between early detection and late detection is measured in quality of life.
Recovery.
Monitor what discharge plans cannot.
Post-surgical complications — cognitive changes, medication-induced movement disorders, onset of depression — appear days or weeks after surgery. By then, the surgeon has moved on. The patient is in a different care setting. The care team has no baseline for comparison. GIA® establishes a speech and cognitive baseline before surgery and monitors for deviation after. When a post-surgical patient's speech patterns shift, the system flags it — before a readmission becomes necessary.
The cost of a missed condition is never zero. It compounds.
An undetected depressive episode leads to medication non-adherence. A missed cognitive decline leads to a fall. A tardive dyskinesia case left unidentified leads to irreversible motor damage. Every unscreened visit is a compounding risk — to the patient, to the facility, to the health system's bottom line.